MBX Biosciences, Inc. (MBX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

MBX Biosciences, Inc. (MBX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

MBX Biosciences, Inc.

· MBX

Dashboard

Financials

Ratios

Valuation

Statistics

2.823 B

-3.53%

General

Market Cap: $2.82B
Enterprise Value: $2.64B
Shares Outstanding: 47,600,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -23.93%
ROE: -26.01%
ROIC: -28.56%
Current Ratio: 18.08
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -5.53
P/S: —
P/FCF: —
P/B: 6.57
EV/EBITDA: -24.48

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $117.92M
Operating Income: -$117.92M
Net Profit: -$104.29M

Balance Sheet

Cash and Equivalents: $54.12M
Working Capital: $404.2M
Total Assets: $435.91M
Net Debt: -$50.78M
Total Liabilities: $26.37M
Total Equity: $409.54M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$82.67M
Cash Flow from Investing: -$180.8M
Cash Flow from Financing: $278.02M
Free Cash Flow: -$85.2M
Capital Expenditures: $2.53M